Literature DB >> 21321122

Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

N Sanjib Banerjee1, Hsu-Kun Wang, Thomas R Broker, Louise T Chow.   

Abstract

The productive program of human papillomaviruses occurs in differentiated squamous keratinocytes. We have previously shown that HPV-18 DNA amplification initiates in spinous cells in organotypic cultures of primary human keratinocytes during prolonged G(2) phase, as signified by abundant cytoplasmic cyclin B1 (Wang, H. K., Duffy, A. A., Broker, T. R., and Chow, L. T. (2009) Genes Dev. 23, 181-194). In this study, we demonstrated that the E7 protein, which induces S phase reentry in suprabasal cells by destabilizing the p130 pocket protein (Genovese, N. J., Banerjee, N. S., Broker, T. R., and Chow, L. T. (2008) J. Virol. 82, 4862-4873), also elicited extensive G(2) responses. Western blots and indirect immunofluorescence assays were used to probe for host proteins known to control G(2)/M progression. E7 expression induced cytoplasmic accumulation of cyclin B1 and cdc2 in the suprabasal cells. The elevated cdc2 had inactivating phosphorylation on Thr(14) or Tyr(15), and possibly both, due to an increase in the responsible Wee1 and Myt1 kinases. In cells that harbored cytoplasmic cyclin B1 or cdc2, there was also an accumulation of the phosphatase-inactive cdc25C phosphorylated on Ser(216), unable to activate cdc2. Moreover, E7 expression induced elevated expression of phosphorylated ATM (Ser(1981)) and the downstream phosphorylated Chk1, Chk2, and JNKs, kinases known to inactivate cdc25C. Similar results were observed in primary human keratinocyte raft cultures in which the productive program of HPV-18 took place. Collectively, this study has revealed the mechanisms by which E7 induces prolonged G(2) phase in the differentiated cells following S phase induction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321122      PMCID: PMC3083224          DOI: 10.1074/jbc.M110.197574

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  The cdc25 protein contains an intrinsic phosphatase activity.

Authors:  W G Dunphy; A Kumagai
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

2.  Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.

Authors:  P R Mueller; T R Coleman; A Kumagai; W G Dunphy
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

3.  The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex.

Authors:  F Liu; J J Stanton; Z Wu; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase.

Authors:  T Herzinger; J O Funk; K Hillmer; D Eick; D A Wolf; P Kind
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

5.  Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.

Authors:  S Cheng; D C Schmidt-Grimminger; T Murant; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

6.  Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.

Authors:  L L Parker; H Piwnica-Worms
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

7.  Membrane localization of the kinase which phosphorylates p34cdc2 on threonine 14.

Authors:  S Kornbluth; B Sebastian; T Hunter; J Newport
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

8.  Cell cycle regulation of the p34cdc2 inhibitory kinases.

Authors:  S Atherton-Fessler; F Liu; B Gabrielli; M S Lee; C Y Peng; H Piwnica-Worms
Journal:  Mol Biol Cell       Date:  1994-09       Impact factor: 4.138

Review 9.  Cdc2 regulatory factors.

Authors:  T R Coleman; W G Dunphy
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

10.  Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.

Authors:  J Pines; T Hunter
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

View more
  59 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Levels of the E2 interacting protein TopBP1 modulate papillomavirus maintenance stage replication.

Authors:  Sriramana Kanginakudru; Marsha DeSmet; Yanique Thomas; Iain M Morgan; Elliot J Androphy
Journal:  Virology       Date:  2015-02-07       Impact factor: 3.616

3.  Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1.

Authors:  Daniel C Anacker; Dipendra Gautam; Kenric A Gillespie; William H Chappell; Cary A Moody
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Jason J Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Human papillomavirus type 16 E7 oncoprotein engages but does not abrogate the mitotic spindle assembly checkpoint.

Authors:  Yueyang Yu; Karl Munger
Journal:  Virology       Date:  2012-06-28       Impact factor: 3.616

6.  Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation.

Authors:  Katarina Kotnik Halavaty; Jennifer Regan; Kavi Mehta; Laimonis Laimins
Journal:  Virology       Date:  2014-02-14       Impact factor: 3.616

Review 7.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

8.  Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.

Authors:  N Sanjib Banerjee; Hsu-Kun Wang; James R Beadle; Karl Y Hostetler; Louise T Chow
Journal:  Antiviral Res       Date:  2017-12-26       Impact factor: 5.970

Review 9.  Impact of Replication Stress in Human Papillomavirus Pathogenesis.

Authors:  Cary A Moody
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Human papillomavirus E7 induces rereplication in response to DNA damage.

Authors:  Xueli Fan; Yingwang Liu; Susan A Heilman; Jason J Chen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.